Novel Use of Hypoxia-Inducible Polymerizable Protein to Augment Chemotherapy for Pancreatic Cancer

Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive malignancies and is the fourth leading cause of cancer-related deaths in the United States. Unfortunately, 80–85% of patients are diagnosed with unresectable, advanced stage tumors. These tumors are incurable and result in a media...

Descripción completa

Detalles Bibliográficos
Autores principales: Gdowski, Andrew, Hayatshahi, Hamed, Fudala, Rafal, Joshi, Rohan, Liu, Jin, Vishwanatha, Jamboor K., Jeyarajah, Rohan, Guzik, Paul, Ranjan, Amalendu P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777667/
https://www.ncbi.nlm.nih.gov/pubmed/35057024
http://dx.doi.org/10.3390/pharmaceutics14010128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777667/
https://www.ncbi.nlm.nih.gov/pubmed/35057024
http://dx.doi.org/10.3390/pharmaceutics14010128

Ejemplares similares